Observational Study To Evaluate Statins Patterns Of Use In Spain

Withdrawn

• Conditions: Dyslipidemia

• Registration Number: NCT01023503
• Lead Sponsor: AstraZeneca

Brief Summary

The present project is aimed at describing the statins prescription pattern in Spanish patients. It will also look into how adequate these prescriptions are accordingly to the recommendations given in Treatment Guidelines and in the Summary Product Information.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-10-31
• Study First Submitted QC: 2009-12-01
• Study First Posted: 2009-12-02
• Study Start: 2011-03
• Primary Completion: 2012-04
• Study Completion: 2012-07
• Status Verified: 2013-07
• Last Update Submitted: 2013-07-23
• Last Update Posted: 2013-07-24

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patients receiving a new statin prescription (naïve patients)
• Patients having a change in their statin prescription (dose, switching, addition to another hypolipemic drug)

Exclusion Criteria

• Patients without enough information in the medical records to complete the fields required in the eCRF

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current and previous hypolipemic treatment, dose and pattern	Retrospectively (information for the previous 6-months). Information collected once.
Statin treatment start date, origin of the prescription, reasons for changes in prescription	Retrospectively (information for the previous 6-months). Information collected once.

Secondary Outcome Measures

Name	Time	Method
Concomitant Treatments and Cardiovascular History	retrospectively
Socio-demographic characteristics	retrospectively
Total Cholesterol, HDL, LDL, Triglycerides, ALAT, Glucose, Creatine Kinase plasma levels	retrospectively

Trial Locations

Locations (1)

Research Site; 🇪🇸 Barcelona, Spain